Service des soins ambulatoires intensifs (SSAI)

Contactez: Gisèle Bélanger gisele.belanger@muhc.mcgill.ca 
Dr Geoffrey Dougherty geoffrey.dougherty@muhc.mcgill.ca au 514-412-4420

• Administration of Blood Products for Patients with Hemophilia and Von Willebrand’s Disease in the IACS
• Administration of Ceftriaxone for the Outpatient Treatment of Cellulitis and Soft Tissue Infections that need Parenteral Antibiotics – A Joint IACS, ID and ER Program
• Administration of DDAVP (Desmopressin Acetate) in Patients with Mild-to-Moderate Factor VIII Deficiency and Patients with Mild-to-Moderate Von Willebrand’s Disease in the IACS and at home
• Administration of Desferal at Home (Desferoxamine Mesylate) and in the IACS
• Administration of Intravenous Gammaglobulin in HIV Patients in the IACS
• Administration of IV Antibiotic at home and in the IACS
• Administration of IV Glucose at home
• Administration of Oral Fibrinolysis Inhibitors in the IACS
  Administration of Pain Medication in Patients with Hemophilia in the IACS
• Administration of Porcine VIII (Hyate C) for Patients with Hemophilia A with Inhibitors
• Administration of Salbutamol Inhalation in the IACS and at home
• Administration of Synagis (Palivizumab) in the IACS
• Adrenocorticoid  Suppression in the IACS and at home
• Blood Drawing in the IACS
• Blood Transfusion Dependent Patients with Thalassemia Major in the IACS
• Follow-Up Guidelines for Cardiac Transplant Patients in the IACS
• Follow-Up Guidelines for Liver Transplant Patients in the IACS
• Hydration of Patients at home
• Insertion, Maintenance and Use of a PICC line in the IACS and at home
• Management of Acute Respiratory Illnesses in Patients with a Degenerative Neuromuscular Disease in the IACS and at home
  Management of Chronic Constipation in Patients with a Degenerative Neuromuscular Disease in the IACS and at home
• Management of Hemophiliacs and Non Hemophiliacs with Factor VIII Inhibitors in the IACS
• Pneumococcal Vaccination in the IACS
• Problem Solving in Transplant Recipient Patients, Off-Hours
• Subcutaneous Home Infusion of Immunoglobulins
• Treatment of Allergic Reactions Following Administration of Blood Products in the IACS
• Treatment of febrile UTI and acute pyelonephritis in children
• Treatment of Patients with Hemophilia A, B, & Von Willebrand’s Disease Off Hours in the Emergency Department
• Treatment with Tisseel (Two-Component Fibrin Sealant) in the IACS
• Use of Humate P in the treatment of Von Willebrand Patients in IACS
• Use of Medical Prescriptions in the IACS
• Use of Recombinant Factor VIIa in Hemophilia